proadifen has been researched along with Lung Diseases in 2 studies
Proadifen: An inhibitor of drug metabolism and CYTOCHROME P-450 ENZYME SYSTEM activity.
Lung Diseases: Pathological processes involving any part of the LUNG.
Excerpt | Relevance | Reference |
---|---|---|
" It is well established that the pneumotoxicity of MCT depends on its hepatic bioactivation to monocrotaline pyrrole (MCTP) and perhaps other toxic metabolites." | 1.27 | Effect of a mixed function oxidase inducer and inhibitor on monocrotaline pyrrole pneumotoxicity. ( Bruner, LH; Carpenter, LJ; Hamlow, P; Roth, RA, 1986) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kehrer, JP | 1 |
Witschi, H | 1 |
Bruner, LH | 1 |
Carpenter, LJ | 1 |
Hamlow, P | 1 |
Roth, RA | 1 |
2 other studies available for proadifen and Lung Diseases
Article | Year |
---|---|
Effects of drug metabolism inhibitors on butylated hydroxytoluene-induced pulmonary toxicity in mice.
Topics: Animals; Antimetabolites; Butylated Hydroxytoluene; DNA; Lung Diseases; Male; Mice; Mice, Inbred BAL | 1980 |
Effect of a mixed function oxidase inducer and inhibitor on monocrotaline pyrrole pneumotoxicity.
Topics: Animals; Enzyme Induction; Heart; Lung Diseases; Magnetic Resonance Spectroscopy; Mass Spectrometry; | 1986 |